Mixed Lymphocyte Reaction (MLR) assay
- T cell activation by monocyte derived dendritic cell assay
- Optimized multiplex compound screening
- Applicable for immuno-oncology, autoimmunity, and drug safety applications
Our suite of ImmuSignatureTM immune cell screening standardized assays have been specifically developed and validated to provide data for your compound screen from 4 weeks. By working with immunology experts to provide consistent, relevant, and robust high-throughput outputs you can free up time and gain the confidence to move your therapeutic forward.
Assess the impairment of T Lymphocyte regulatory cells and the effectiveness of therapeutic candidates